The Goldman Sachs Group, Inc. 13D and 13G filings for Vincerx Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-04-09 5:09 pm Sale |
2024-03-28 | 13G | Vincerx Pharma, Inc. VINC |
GOLDMAN SACHS GROUP INC GS |
31,575 3.000% |
-53,908 (-63.06%) |
Filing |
| 2024-02-05 5:35 pm Sale |
2023-12-29 | 13G | Vincerx Pharma, Inc. VINC |
GOLDMAN SACHS GROUP INC GS |
85,483 8.000% |
-21,910 (-20.40%) |
Filing |
| 2023-02-10 1:46 pm Purchase |
2023-01-31 | 13G | Vincerx Pharma, Inc. VINC |
GOLDMAN SACHS GROUP INC GS |
107,392 10.100% |
3,549 (+3.42%) |
Filing |
| 2023-02-08 09:53 am Purchase |
2022-12-30 | 13G | Vincerx Pharma, Inc. VINC |
GOLDMAN SACHS GROUP INC GS |
103,844 9.800% |
103,844 (New Position) |
Filing |